Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations.

Wlodarska I, Veyt E, De Paepe P, Vandenberghe P, Nooijen P, Theate I, Michaux L, Sagaert X, Marynen P, Hagemeijer A, De Wolf-Peeters C.

Leukemia. 2005 Aug;19(8):1299-305.

PMID:
15944719
2.

Bone and brain involvement in a case of diffuse large B cell lymphoma associated with t(2;3)(p12;q27).

Utsumi S, Miura I, Takahashi N, Ohshima A, Nimura T, Hashimoto K, Chubachi A, Saito M, Takatsu H, Yamaguchi A, et al.

Int J Hematol. 1995 Dec;62(4):247-52. Review.

PMID:
8589371
3.

Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).

Iida S, Rao PH, Ueda R, Chaganti RS, Dalla-Favera R.

Leuk Lymphoma. 1999 Jun;34(1-2):25-33. Review.

PMID:
10350329
4.

The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.

Ohno H, Ueda C, Akasaka T.

Leuk Lymphoma. 2000 Feb;36(5-6):435-45. Review.

PMID:
10784387
5.

FOXP1: a potential therapeutic target in cancer.

Koon HB, Ippolito GC, Banham AH, Tucker PW.

Expert Opin Ther Targets. 2007 Jul;11(7):955-65. Review.

6.

Structural genomic alterations in primary mediastinal large B-cell lymphoma.

Twa DD, Steidl C.

Leuk Lymphoma. 2015;56(8):2239-50. doi: 10.3109/10428194.2014.985673. Epub 2015 Jan 21. Review.

PMID:
25393674

Supplemental Content

Support Center